Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12613001159741
Ethics application status
Approved
Date submitted
2/10/2013
Date registered
18/10/2013
Date last updated
4/01/2017
Type of registration
Prospectively registered

Titles & IDs
Public title
Sprayed Peritoneal Regional Analgesia in Appendicectomy trial - SPRAY trial
Scientific title
In children undergoing laparoscopic appendicectomy for acute appendicitis, does local anaesthetic sprayed onto the peritoneum, compared to saline, reduce post-operative pain.
Secondary ID [1] 283341 0
Nil
Universal Trial Number (UTN)
U1111-1148-7094
Trial acronym
SPRAY trial
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Acute appendicitis 290235 0
Condition category
Condition code
Surgery 290627 290627 0 0
Surgical techniques
Anaesthesiology 290709 290709 0 0
Anaesthetics
Oral and Gastrointestinal 290710 290710 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Peritoneal spray of local anaesthetic, bupivacaine, at a concentration of 0.125%, will be sprayed only the peritoneum of the right iliac fossa and pelvis during laparoscopic surgery for suspected appendicitis.
Intervention code [1] 288064 0
Treatment: Drugs
Comparator / control treatment
Peritoneal spray of normal saline
Control group
Placebo

Outcomes
Primary outcome [1] 290640 0
Global pain scores using the Revised Faces Pain Scale (FPS-r), and a novel pain location tool developed by our unit (the Location and Level of Intensity of Postoperative Pain Score - Lolipops).
Timepoint [1] 290640 0
Post-operative hours 0-3, 3-6, 6-12, 12-18 and 18-24.
Secondary outcome [1] 304962 0
Morphine equivalent daily dose
Timepoint [1] 304962 0
24 hours
Secondary outcome [2] 304963 0
Proportion of patients who required opiate analgesia
Timepoint [2] 304963 0
24 hours
Secondary outcome [3] 304964 0
Length of hospital stay
Timepoint [3] 304964 0
30 days

Eligibility
Key inclusion criteria
Acute appendicitis
Children aged 8 years and older
Minimum age
8 Years
Maximum age
15 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Developmental delay, neuro-muscular impairment, attention-deficit disorder, chronic pain, or psychiatric illness.
Unable to speak and read English
Partially sighted or blind
Presence of any abdominal prostheses such as a gastrostomy or ventriculo-peritoneal shunt
Allergy to bupivacaine
Consent not obtained from both the participating child and a parent or legal guardian

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Children will be enrolled by surgical staff on presentation with acute appendicitis. Allocation will be by sealed opaque envelopes. Two theatre nurses will be aware of the allocation in order to prepare the intervention solution, but will not divulge the allocation to any other staff members or investigators.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
The sequence will be generated using an on-line random number generator (random.org) by a research assistant not involved in any other aspect of the trial.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 4
Type of endpoint/s
Efficacy
Statistical methods / analysis
Parametric or nonparametric tests (according to normality of data) comparing two groups.
A sample size calculation was based on pain score data from a previous study on pain after appendicectomy. To obtain a 30% (3 points on a 0-10 pain scale) reduction in pain, with alpha 0.05 and 1-beta 0.9, 174 participants will be required.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
15/01/2014
Actual
21/05/2014
Date of last participant enrolment
Anticipated
21/05/2015
Actual
9/03/2015
Date of last data collection
Anticipated
Actual
20/04/2015
Sample size
Target
174
Accrual to date
Final
175
Recruitment outside Australia
Country [1] 5457 0
New Zealand
State/province [1] 5457 0

Funding & Sponsors
Funding source category [1] 288073 0
Charities/Societies/Foundations
Name [1] 288073 0
A+ Trust
Country [1] 288073 0
New Zealand
Primary sponsor type
University
Name
The University of Auckland Department of Surgery
Address
Department of Surgery
Faculty of Medicine and Health Sciences
The University of Auckland
Private Bag 92019
Auckland Mail Centre 1142
Country
New Zealand
Secondary sponsor category [1] 286795 0
None
Name [1] 286795 0
Address [1] 286795 0
Country [1] 286795 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 290000 0
Health and Disability Ethics Committee
Ethics committee address [1] 290000 0
Ethics committee country [1] 290000 0
New Zealand
Date submitted for ethics approval [1] 290000 0
02/10/2013
Approval date [1] 290000 0
10/02/2014
Ethics approval number [1] 290000 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes
Attachments [1] 626 626 0 0
/AnzctrAttachments/365082-Study Protocol v4a.pdf

Contacts
Principal investigator
Name 43386 0
Dr James Hamill
Address 43386 0
Starship Children's Hospital
Private Bag 92024
Auckland 1142
Country 43386 0
New Zealand
Phone 43386 0
+64 9 3797440
Fax 43386 0
Email 43386 0
jamesh@adhb.govt.nz
Contact person for public queries
Name 43387 0
James Hamill
Address 43387 0
Starship Children's Hospital
Private Bag 92024
Auckland 1142
Country 43387 0
New Zealand
Phone 43387 0
+64 9 3797440
Fax 43387 0
Email 43387 0
jamesh@adhb.govt.nz
Contact person for scientific queries
Name 43388 0
James Hamill
Address 43388 0
Starship Children's Hospital
Private Bag 92024
Auckland 1142
Country 43388 0
New Zealand
Phone 43388 0
+64 9 3797440
Fax 43388 0
Email 43388 0
jamesh@adhb.govt.nz

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.